BR112012001900A2 - otamixabano para tratamento de pacientes idosos com insuficiência renal e infarto do miocárdio sem elevação do st - Google Patents
otamixabano para tratamento de pacientes idosos com insuficiência renal e infarto do miocárdio sem elevação do stInfo
- Publication number
- BR112012001900A2 BR112012001900A2 BR112012001900A BR112012001900A BR112012001900A2 BR 112012001900 A2 BR112012001900 A2 BR 112012001900A2 BR 112012001900 A BR112012001900 A BR 112012001900A BR 112012001900 A BR112012001900 A BR 112012001900A BR 112012001900 A2 BR112012001900 A2 BR 112012001900A2
- Authority
- BR
- Brazil
- Prior art keywords
- otamixaban
- elevating
- treatment
- myocardial infarction
- renal failure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09290601 | 2009-07-29 | ||
| EP10305192 | 2010-02-26 | ||
| PCT/EP2010/060615 WO2011012527A1 (en) | 2009-07-29 | 2010-07-22 | Otamixaban for treatment of elderly and renal impaired non-st elevation myocardial infarction patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012001900A2 true BR112012001900A2 (pt) | 2016-03-15 |
Family
ID=42542846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012001900A BR112012001900A2 (pt) | 2009-07-29 | 2010-07-22 | otamixabano para tratamento de pacientes idosos com insuficiência renal e infarto do miocárdio sem elevação do st |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US9492437B2 (pt) |
| EP (1) | EP2459193A1 (pt) |
| JP (1) | JP2013500298A (pt) |
| KR (1) | KR20120038982A (pt) |
| CN (1) | CN102470128A (pt) |
| AR (1) | AR077427A1 (pt) |
| AU (1) | AU2010277725B2 (pt) |
| BR (1) | BR112012001900A2 (pt) |
| CA (1) | CA2766533A1 (pt) |
| CL (1) | CL2012000196A1 (pt) |
| CO (1) | CO6491041A2 (pt) |
| CR (1) | CR20110674A (pt) |
| DO (1) | DOP2012000012A (pt) |
| EC (1) | ECSP12011627A (pt) |
| IL (1) | IL217612A (pt) |
| MA (1) | MA33455B1 (pt) |
| MX (1) | MX2012000457A (pt) |
| NI (1) | NI201200008A (pt) |
| NZ (1) | NZ597957A (pt) |
| PE (1) | PE20121401A1 (pt) |
| RU (1) | RU2542455C2 (pt) |
| SG (1) | SG177772A1 (pt) |
| TW (1) | TWI463982B (pt) |
| UY (1) | UY32807A (pt) |
| WO (1) | WO2011012527A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2597423C2 (ru) * | 2011-03-29 | 2016-09-10 | Санофи | Бензойнокислая соль отамиксабана |
| TWI551289B (zh) * | 2011-03-29 | 2016-10-01 | 賽諾菲公司 | 具有改良之安定性之奧米沙班調配物 |
| AU2012234323A1 (en) | 2011-03-29 | 2013-10-17 | Sanofi | Otamixaban formulations with improved stability |
| CA2883625A1 (en) * | 2012-08-31 | 2014-03-06 | Sanofi | Otamixaban for use in the treatment of non-st elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273128C (zh) * | 1996-01-02 | 2006-09-06 | 阿温蒂斯药物公司 | 取代的n－[(氨基亚氨基甲基或氨基甲基)苯基]丙基酰胺 |
| RU2225617C1 (ru) * | 2002-12-16 | 2004-03-10 | Научно-исследовательский институт кардиологии Томского научного центра СО РАМН | Способ определения дифференцированного назначения гепаринов больным с острым коронарным синдромом без подъема сегмента st |
-
2010
- 2010-07-22 JP JP2012522112A patent/JP2013500298A/ja active Pending
- 2010-07-22 CA CA2766533A patent/CA2766533A1/en not_active Abandoned
- 2010-07-22 WO PCT/EP2010/060615 patent/WO2011012527A1/en active Application Filing
- 2010-07-22 RU RU2012107483/15A patent/RU2542455C2/ru not_active IP Right Cessation
- 2010-07-22 PE PE2012000036A patent/PE20121401A1/es not_active Application Discontinuation
- 2010-07-22 MA MA34566A patent/MA33455B1/fr unknown
- 2010-07-22 BR BR112012001900A patent/BR112012001900A2/pt not_active IP Right Cessation
- 2010-07-22 MX MX2012000457A patent/MX2012000457A/es active IP Right Grant
- 2010-07-22 KR KR1020127002078A patent/KR20120038982A/ko not_active Application Discontinuation
- 2010-07-22 NZ NZ597957A patent/NZ597957A/en not_active IP Right Cessation
- 2010-07-22 CN CN2010800323309A patent/CN102470128A/zh active Pending
- 2010-07-22 AU AU2010277725A patent/AU2010277725B2/en not_active Ceased
- 2010-07-22 US US13/387,639 patent/US9492437B2/en not_active Expired - Fee Related
- 2010-07-22 EP EP10735284A patent/EP2459193A1/en not_active Withdrawn
- 2010-07-22 SG SG2012006110A patent/SG177772A1/en unknown
- 2010-07-27 TW TW099124612A patent/TWI463982B/zh not_active IP Right Cessation
- 2010-07-27 AR ARP100102707A patent/AR077427A1/es unknown
- 2010-07-27 UY UY0001032807A patent/UY32807A/es not_active Application Discontinuation
-
2011
- 2011-12-15 CR CR20110674A patent/CR20110674A/es unknown
-
2012
- 2012-01-12 NI NI201200008A patent/NI201200008A/es unknown
- 2012-01-16 CO CO12005490A patent/CO6491041A2/es not_active Application Discontinuation
- 2012-01-18 IL IL217612A patent/IL217612A/en not_active IP Right Cessation
- 2012-01-19 DO DO2012000012A patent/DOP2012000012A/es unknown
- 2012-01-24 CL CL2012000196A patent/CL2012000196A1/es unknown
- 2012-01-26 EC EC2012011627A patent/ECSP12011627A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ597957A (en) | 2014-05-30 |
| WO2011012527A1 (en) | 2011-02-03 |
| KR20120038982A (ko) | 2012-04-24 |
| AU2010277725A1 (en) | 2012-02-16 |
| IL217612A (en) | 2014-08-31 |
| NI201200008A (es) | 2012-05-29 |
| CN102470128A (zh) | 2012-05-23 |
| TWI463982B (zh) | 2014-12-11 |
| CR20110674A (es) | 2012-04-17 |
| AR077427A1 (es) | 2011-08-24 |
| AU2010277725B2 (en) | 2016-08-18 |
| JP2013500298A (ja) | 2013-01-07 |
| PE20121401A1 (es) | 2012-10-25 |
| US9492437B2 (en) | 2016-11-15 |
| DOP2012000012A (es) | 2012-02-15 |
| MX2012000457A (es) | 2012-01-27 |
| SG177772A1 (en) | 2012-03-29 |
| RU2542455C2 (ru) | 2015-02-20 |
| MA33455B1 (fr) | 2012-07-03 |
| EP2459193A1 (en) | 2012-06-06 |
| TW201119655A (en) | 2011-06-16 |
| UY32807A (es) | 2011-02-28 |
| CO6491041A2 (es) | 2012-07-31 |
| ECSP12011627A (es) | 2012-02-29 |
| CL2012000196A1 (es) | 2012-10-05 |
| RU2012107483A (ru) | 2013-09-10 |
| US20120238605A1 (en) | 2012-09-20 |
| CA2766533A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1217293A1 (zh) | 預防或治療心力衰竭的方法 | |
| EP2496299A4 (en) | MULTILAYER FIBER-DEVICE FOR THE TREATMENT OF VASCULAR DEFECTS | |
| BR112012025961A2 (pt) | composição farmacêutica oral, forma de dosagem de undecanoato de testosterona e método de tratar deficiência de testosterona ou seus sintomas | |
| FR2948016B1 (fr) | Orthese pour le traitement de la rhizarthrose | |
| FI20095836A (fi) | Probioottinen valmiste koirien maha- ja suolistohäiriöiden ennaltaehkäisyyn tai hoitoon | |
| BRPI1008023A2 (pt) | forma de dosagem sólida | |
| BRPI1012116A2 (pt) | composição farmacêutica para o tratamento de doenças cardíacas | |
| HK1171168A1 (zh) | 利用拉喹莫德治療克羅恩病 | |
| PL2115477T3 (pl) | Zastosowanie IGFBP-7 do oceny niewydolności serca | |
| DK2319462T3 (da) | Protese med komposit komponent | |
| DK3033984T3 (da) | Håndholdt gulvbehandlingsapparat | |
| DK2617392T3 (da) | Protese med overflader med forskellige teksturer | |
| ZA201204521B (en) | Beta-cell replication promoting compounds and methods of the their use | |
| UY33094A (es) | Procedimiento para la preparacion de dronedarona | |
| BR112012002571A2 (pt) | tratamento de minérios de titânio | |
| IL218971A0 (en) | Sulfoxide derivatives for the treatment of tumours | |
| GB0700972D0 (en) | Treatment of inflammatory disease | |
| BR112013014811A2 (pt) | composição de tratamento de pano | |
| EP2440216A4 (en) | USE OF A COMPOSITION FOR TREATING MUCOSITIS | |
| BR112013014915A2 (pt) | composição curativa e métodos de tratamento | |
| BR112012001900A2 (pt) | otamixabano para tratamento de pacientes idosos com insuficiência renal e infarto do miocárdio sem elevação do st | |
| GB0720976D0 (en) | Treatment of inflammatory disease | |
| EP2383272A4 (en) | INHIBITOR OF AN ACTIVE FACTOR OF BLOOD COAGULATION | |
| BRPI1009322A2 (pt) | dose de ave5026 para o tratamento de tromboembolia venosa em pacientes com deficiência renal grave | |
| IL205675A0 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2471 DE 15-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |